Compare SAMRAT PHARMA with Piramal Enterprises - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA PIRAMAL ENTERPRISES SAMRAT PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 12.3 57.5 21.5% View Chart
P/BV x 2.8 1.7 168.0% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 SAMRAT PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-20
PIRAMAL ENTERPRISES
Mar-21
SAMRAT PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1322,008 6.6%   
Low Rs47806 5.8%   
Sales per share (Unadj.) Rs381.2567.9 67.1%  
Earnings per share (Unadj.) Rs13.747.6 28.8%  
Cash flow per share (Unadj.) Rs15.172.5 20.8%  
Dividends per share (Unadj.) Rs033.00 0.0%  
Avg Dividend yield %02.3 0.0%  
Book value per share (Unadj.) Rs78.71,508.3 5.2%  
Shares outstanding (eoy) m3.09225.54 1.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.22.5 9.5%   
Avg P/E ratio x6.529.5 22.1%  
P/CF ratio (eoy) x5.919.4 30.6%  
Price / Book Value ratio x1.10.9 122.0%  
Dividend payout %069.3 0.0%   
Avg Mkt Cap Rs m277317,310 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1016,505 0.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,178128,094 0.9%  
Other income Rs m63,636 0.2%   
Total revenues Rs m1,184131,730 0.9%   
Gross profit Rs m6675,231 0.1%  
Depreciation Rs m45,609 0.1%   
Interest Rs m1042,085 0.0%   
Profit before tax Rs m5831,173 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1520,429 0.1%   
Profit after tax Rs m4210,744 0.4%  
Gross profit margin %5.658.7 9.6%  
Effective tax rate %26.865.5 40.8%   
Net profit margin %3.68.4 42.9%  
BALANCE SHEET DATA
Current assets Rs m497198,674 0.3%   
Current liabilities Rs m339133,473 0.3%   
Net working cap to sales %13.450.9 26.3%  
Current ratio x1.51.5 98.5%  
Inventory Days Days11,685 0.1%  
Debtors Days Days864 1,958.0%  
Net fixed assets Rs m87627,818 0.0%   
Share capital Rs m31451 6.8%   
"Free" reserves Rs m212339,729 0.1%   
Net worth Rs m243340,180 0.1%   
Long term debt Rs m0280,968 0.0%   
Total assets Rs m583826,493 0.1%  
Interest coverage x6.91.7 397.3%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x2.00.2 1,302.5%   
Return on assets %8.96.4 139.8%  
Return on equity %17.43.2 551.9%  
Return on capital %27.811.8 235.9%  
Exports to sales %5.90-   
Imports to sales %94.70.1 88,542.3%   
Exports (fob) Rs m69NA-   
Imports (cif) Rs m1,115137 814.2%   
Fx inflow Rs m691,116 6.2%   
Fx outflow Rs m1,116137 814.3%   
Net fx Rs m-1,046979 -106.8%   
CASH FLOW
From Operations Rs m-1336,645 -0.0%  
From Investments Rs m-19-27,723 0.1%  
From Financial Activity Rs m2020,716 0.1%  
Net Cashflow Rs m-1229,701 -0.0%  

Share Holding

Indian Promoters % 47.8 50.7 94.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 30.9 10.5%  
FIIs % 3.2 26.1 12.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 52.2 49.3 105.7%  
Shareholders   2,234 120,028 1.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   KIMIA BIOSCIENCES  INDOCO REMEDIES  BROOKS LAB  MESCO PHARMA  SANOFI INDIA  



Today's Market

5 Factors Why Stock Markets Crashed, Dish TV's AGM, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended deep in the red yesterday. Tracking a rout in the global markets, benchmark indices tumbled for the second day.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY22); Net Profit Down 20.0% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (down 20.0% YoY). Sales on the other hand came in at Rs 29 bn (down 1.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SAMRAT PHARMA SHARE PRICE


Sep 20, 2021 (Close)

TRACK SAMRAT PHARMA

  • Track your investment in SAMRAT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SAMRAT PHARMA 8-QTR ANALYSIS

COMPARE SAMRAT PHARMA WITH

MARKET STATS